Evidence map›Paper›PMID 39474814›Full record

ReviewBioanalysis2024

Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox.

Robert Hart, Shane Karnik, Kathy Van Sickle, Mark Mullin, Odin Naderer, Tim Tippin, John Dunn

Abstract readReview
In one paragraph

Review in Bioanalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert HartClinical Pharmacology and Translational Medicine, Chimerix, Inc., Durham, NC 27705, USA.ORCID 0009-0007-8101-5202
Shane KarnikLaboratory operations, Colorado, Aliri Bioanalysis, Colorado Springs, CO 80907, USA.ORCID 0000-0001-7019-7724
Kathy Van SickleClinical Pharmacology and Translational Medicine, Chimerix, Inc., Durham, NC 27705, USA.
Mark MullinClinical Pharmacology and Translational Medicine, Chimerix, Inc., Durham, NC 27705, USA.ORCID 0000-0001-8730-5795
Odin NadererClinical Pharmacology and Translational Medicine, Chimerix, Inc., Durham, NC 27705, USA.ORCID 0009-0002-0809-274X
Tim TippinClinical Pharmacology and Translational Medicine, Chimerix, Inc., Durham, NC 27705, USA.
John DunnClinical Pharmacology and Translational Medicine, Chimerix, Inc., Durham, NC 27705, USA.

Funding

Biomedical Advanced Research and Development Authority HHSO100201100013C
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CytosineLeukocytes, MononuclearOrganophosphonatesAnimalsAntiviral AgentsCell SeparationHumansMiceNucleotidesRabbitsSmallpoxTandem Mass SpectrometryAntiviral AgentsbrincidofovirCytosineNucleotidesOrganophosphonatesbrincidofovirdensity gradient centrifugationFDA animal ruleLC-MS/MSPBMC

Identifiers

PMID39474814
PMCPMC11583588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.